Business Context and Reporting Period
Company: Teleflex Incorporated
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended September 26, 1999
Business Overview: Teleflex operates through three primary segments: Commercial (Automotive, Marine, Industrial), Medical (Hospital Supply, Surgical Devices), and Aerospace (Cargo systems, Turbo-machinery, Manufactured components). The company reported 37,971,490 shares of Common Stock outstanding as of September 26, 1999.
Key Financial Metrics
| Metric (in thousands) | Q3 1999 | Q3 1998 | 9 Months 1999 | 9 Months 1998 |
|---|---|---|---|---|
| Revenues | $377,391 | $342,962 | $1,190,707 | $1,051,733 |
| Net Income | $18,986 | $16,177 | $67,894 | $57,279 |
| Diluted EPS | $0.49 | $0.42 | $1.76 | $1.49 |
| Operating Profit | $37,886 | $33,086 | $129,394 | $113,565 |
| Operating Margin | 10.0% | 9.6% | 10.9% | 10.8% |
| Gross Profit Margin | 27.7% | 28.0% | 28.3% | 28.5% |
| Cash from Operations (9mo) | $82,398 (vs $102,532 prior year) | |||
| Long-Term Borrowings | $280,264 (as of Sept 26, 1999) | |||
| Cash & Equivalents | $46,200 (as of Sept 26, 1999) |
Material Changes vs. Prior Period
- Revenue Growth: Q3 1999 revenues increased 10% to $377.4 million. Approximately 50% of this growth was attributed to acquisitions, with the remainder generated organically.
- Segment Performance:
- Commercial: Sales up 15% and operating profit up 33% (margin improved to 7.1%). Growth driven by Marine and Industrial lines; Automotive profits remained flat due to investment costs.
- Medical: Sales up 9% and operating profit up 21% (margin improved to 13.2%). Driven by acquisitions in Europe and the U.S. and higher-margin product sales.
- Aerospace: Sales up 4% but operating profit declined 2% (margin dropped to 11.7%). Caused by a volume decline in manufactured components and a shift to lower-margin turbo-machinery and repair services.
- Profitability: Net income increased 17% in Q3. Operating expenses as a percentage of sales decreased to 18.9% from 19.6%.
- Liquidity: Cash and cash equivalents decreased from $66.7 million to $46.2 million. Cash flow from operations decreased by $20.1 million year-over-year due to increased working capital requirements related to sales volume.
Outlook, Risks, and Management Commentary
- Year 2000 Compliance: Management states that substantially all remediation activities for the Year 2000 issue were completed as of September 26, 1999. Total estimated costs are $10-$12 million, with $9.3 million already spent. Risks remain regarding the readiness of customers and suppliers, though the company's diversified operations mitigate the risk of significant disruption.
- Debt and Capitalization: Long-term borrowings increased slightly to $280.3 million. The ratio of long-term borrowings to total capitalization improved to 32% from 34%.
- Forward-Looking Statements: The report includes standard disclaimers that future results depend on assumptions and estimates subject to risks and uncertainties.
- Dividends: Dividends per share for the nine months ended Sept 26, 1999, were $0.375, compared to $0.330 in the prior year.
Investor Verification Checklist
- Verify the sustainability of the 10% revenue growth, specifically the portion attributed to acquisitions versus organic growth.
- Monitor the Aerospace segment's margin compression and volume decline in manufactured components.
- Assess the impact of working capital increases on future cash flow from operations.
- Confirm the status of Year 2000 readiness for key suppliers and customers to evaluate potential operational disruption risks.
- Review the specific details of the acquisitions in the Medical segment to understand their contribution to the 21% operating profit increase.